Transformation of Cemento-Ossifying Fibroma into Osteosarcoma after Radiotherapy and Nine Endoscopic Surgeries

Cemento-ossifying fibromas (COFs) are benign fibro-osseous tumors usually found in the mandible and maxilla that can show malignancy in rare situations. COFs usually grow slowly and asymptomatically until they produce local bulges, pain, headaches, and visual impairment, and have a Ki-67 index within 3%, even in aggressive and recurrent cases. Surgical resection can usually provide a satisfactory prognosis. However, no cases of COF transforming into osteosarcoma have been reported. We present a case of COF involving a 58-year-old woman whose initial symptom was hearing loss in the right ear accompanied by tinnitus. Enhanced magnetic resonance imaging revealed a 3.1 cm x 3.2 cm mass centered on the right pterygoid process of the sphenoid bone. Postoperative pathology revealed a COF with a high Ki-67 index (8%–10%). Over the next two years, the tumor relapsed repeatedly. The patient underwent nine endoscopic surgeries and radiotherapy. The sixth postoperative biopsy showed that the COF had transformed into an osteosarcoma. The patient subsequently experienced respiratory and cardiac arrests and was receiving treatment in the intensive care unit with a poor prognosis at the time of writing this manuscript. Thus, a high Ki-67 index may be a risk factor for malignant transformation for COFs.

[1]  J. Lai,et al.  Fibro‐osseous Lesions of Paranasal Sinus and Craniofacial Region: A Retrospective Study of 282 Cases , 2020, The Laryngoscope.

[2]  P. Gándara-Vila,et al.  Clinicopathological features of peripheral ossifying fibroma in a series of 41 patients. , 2019, The British journal of oral & maxillofacial surgery.

[3]  Jiang Du,et al.  Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis. , 2019, World neurosurgery.

[4]  C. Guruvayoorappan,et al.  Ki-67 protein as a tumour proliferation marker. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[5]  B. Chrcanovic,et al.  Juvenile ossifying fibroma of the jaws and paranasal sinuses: a systematic review of the cases reported in the literature. , 2019, International journal of oral and maxillofacial surgery.

[6]  V. C. de Araújo,et al.  Microvessel density and cell proliferation in juvenile ossifying fibroma: A comparative study with central ossifying fibroma. , 2018, Annals of diagnostic pathology.

[7]  W. Mendenhall,et al.  Radiotherapy for juvenile ossifying fibroma of the maxillary sinus: Case report and literature review , 2017, Head & neck.

[8]  P. Speight,et al.  New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours , 2017, Virchows Archiv.

[9]  Kehu Yang,et al.  Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis. , 2017, Future oncology.

[10]  R. Mladina,et al.  Endonasal endoscopic resection of ossifying fibroma involving the ethmoid sinus, orbit and anterior skull base: case report and literature review , 2016, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[11]  P. Herman,et al.  Ossifying fibromas of the paranasal sinuses: diagnosis and management , 2015, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[12]  Jiake Xu,et al.  The role of SATB2 in skeletogenesis and human disease. , 2014, Cytokine & growth factor reviews.

[13]  J. Hornick,et al.  SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours , 2013, Histopathology.

[14]  C. Woernle,et al.  Case Report: Trabecular Juvenile Ossifying Fibroma Presenting as a Sellar Mass , 2012, Journal of Neurological Surgery—Part A.

[15]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[16]  W. Jonat,et al.  Is the Ki-67 labelling index ready for clinical use? , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  D. Baird,et al.  Radiotherapy of a recurrent ossifying fibroma in the paranasal sinuses of a horse. , 2004, Journal of the American Veterinary Medical Association.

[18]  F. Lacombe,et al.  Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. , 1991, Cytometry.

[19]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.